AAM
RXDX
AR Asset Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-50,414
| Closed | -$5.41M | – | 113 |
|
|
2023
Q1 | $5.41M | Sell |
50,414
-400
| -0.8% | -$42.9K | 1.46% | 22 |
|
|
2022
Q4 | $5.59M | Sell |
50,814
-233
| -0.5% | -$25.6K | 1.59% | 20 |
|
|
2022
Q3 | $3.01M | Buy |
51,047
+1,000
| +2% | +$59K | 0.9% | 37 |
|
|
2022
Q2 | $1.41M | Buy |
50,047
+22,190
| +80% | +$627K | 0.4% | 60 |
|
|
2022
Q1 | $1.05M | Hold |
27,857
| – | – | 0.27% | 69 |
|
|
2021
Q4 | $1.1M | Buy |
+27,857
| New | +$1.1M | 0.28% | 68 |
|